middle.news

How Is AVITA Medical Advancing Wound Care with Its Latest Q2 Filing?

1:31pm on Friday 8th of August, 2025 AEST Healthcare
Read Story

How Is AVITA Medical Advancing Wound Care with Its Latest Q2 Filing?

1:31pm on Friday 8th of August, 2025 AEST
Key Points
  • Filed Q2 2025 Form 10-Q with SEC
  • Highlights FDA-approved RECELL System for burn and trauma wounds
  • Exclusive rights to market PermeaDerm and Cohealyx in the U.S.
  • International approvals include TGA, CE mark, and PMDA
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Avita Medical (ASX:AVH)
OPEN ARTICLE